SRF Limited, a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates today announced its consolidated financial results for the fourth quarter and year ended March 31, 2025. 

The consolidated revenue of the company increased 21% from Rs. 3,570 crore to Rs. 4,313 crore in Q4FY25 when compared with Corresponding Period Last Year (CPLY). The company’s Earnings before Interest and Tax (EBIT) increased 47% from Rs. 616 crore to Rs. 906 crore in Q4FY25 when compared with CPLY. 

The company’s Profit before Tax (PBT) increased 60% from Rs. 443 crore to Rs. 707 crore in Q4 FY25 when compared with CPLY. In Q4FY25, the company recorded a Profit after Tax (PAT) of Rs. 526 crore. 

Commenting on the results, Chairman and Managing Director, Ashish Bharat Ram said, “We have finished the year on a very strong note, supported by seasonal factors. That aside, we will go into the new financial year carrying this momentum. However, we are dealing with a very volatile global economy at the moment and while we remain cautiously optimistic about the year ahead, the risks remain”. 

The Chemicals Business reported an increase of 30% in its segment revenue from Rs. 1,816 crore to Rs. 2,355 crore during Q4 FY25 over CPLY. The operating profit of the Chemicals Business increased 50% from Rs. 498 crore to Rs. 748 crore in Q4FY25 over CPLY. During the quarter, the Specialty Chemicals Business demonstrated strong performance, driven by positive momentum in recently launched products and a pick-up in demand for certain key agrochemical intermediates. Our cost-competitive pricing strategies, along with robust export market performance, further contributed to revenue growth. 

In Q4FY25, the performance of the Fluorochemicals Business was robust due to strong domestic demand for refrigerants, particularly for Room Air Conditioners, resulting in record-high domestic sales of refrigerant gases. 

Consolidated Annual Results 

In FY25, SRF’s revenue increased 12% from Rs. 13,139 crore to Rs. 14,693 crore over CPLY. The company’s EBIT increased 6% from Rs. 2,201 crore to Rs. 2,336 crore over CPLY, despite a challenging H1 FY25. The company's PBT was Rs. 1,704 crore, nearly unchanged from the previous year's Rs. 1,692 crore. The company registered a PAT of Rs. 1,251 crore in FY25.